Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656460 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer
A NA study of Lung Cancer, sponsored by Dr Thomas DiPetrillo.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT01656460: Completed NA study of Lung Cancer, sponsored by Dr Thomas DiPetrillo.
NCT01656460 is a NA study of Lung Cancer that has completed, run by Dr Thomas DiPetrillo. The registered enrollment target is 12 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01656460, a NA study of Lung Cancer, has completed, sponsored by Dr Thomas DiPetrillo.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the efficacy and toxicity stereotactic body radiation (SBRT) as consolidation following standard chemoradiation for patients with stage III non-small cell lung cancer.
Primary Outcome
Any toxicity related to the radiation treatment will be scored and graded using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Serious adverse events will be captured from the time the patient signs consent until 12 weeks after the last SBRT. DLTS: defined in protocol as: Dose limiting toxicities will be defined as grade 3 or greater treatment related pneumonitis, cardiac toxicity, bronchial injury or chest wall pain during or within 4 weeks of comp
Conditions Studied
Interventions
- RADIATION Stereotactic radiation Arm 1
- RADIATION Stereotactic radiation Arm 2
- RADIATION Stereotactic radiation Arm 3
- RADIATION Stereotactic radiation Arm 4
Study Locations (2)
Rhode Island
- memorial Hospital of Rhode island - Pawtucket
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-04 |
| Est. Completion | 2017-05-16 |
| Phase | NA |
What the finished NCT01656460 record still lists
NCT01656460 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Stereotactic radiation Arm 1 is the first listed.
NCT01656460 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01656460 about?
NCT01656460 is a clinical study titled "Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer". The purpose of this study is to evaluate the efficacy and toxicity stereotactic body radiation (SBRT) as consolidation following standard chemoradiation for patients with stage III non-small cell lung cancer.
What is the current status of trial NCT01656460?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2012-04. Estimated completion is 2017-05-16.
What conditions does trial NCT01656460 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT01656460?
The interventions under investigation include: Stereotactic radiation Arm 1 (RADIATION), Stereotactic radiation Arm 2 (RADIATION), Stereotactic radiation Arm 3 (RADIATION), Stereotactic radiation Arm 4 (RADIATION).
Who is sponsoring clinical trial NCT01656460?
This trial is sponsored by Dr Thomas DiPetrillo, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01656460 being conducted?
This trial has 2 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01656460's enrollment target sits among peer trials
12 385th of 409 higher than 22 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia